SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-17
👔
IceCure Medical Ltd.
@ICCM_InsiderForm 4 Filing: Tel-Tzure Tlalit Bussi Acquires (Grant) shares of $ICCM
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
IceCure Medical Ltd.
Ticker: $ICCM
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-08-14
Shares: 101,483
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Tel-Tzure Tlalit Bussi, holds the title of VP, BD & Global Marketing at IceCure Medical Ltd..
On 2026-08-14, the insider transacted 101,483 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Tel-Tzure Tlalit Bussi (VP, BD & Global Marketing) was granted $0 of $ICCM
Post-Transaction Position: 106,518 shares
SEC Accession No: 0001213900-26-090510 (CIK: 2040298)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.